Psychedelic Psychotherapy

Top Rated5(1 reviews)

Psychedelic Psychotherapy is an emerging area of mental health treatment that combines structured psychotherapy with carefully supervised use of psychedelic-assisted medicines. This Continuing Professional Development (CPD) course provides healthcare professionals with an evidence-based overview of psychedelic-assisted psychotherapy, including therapeutic models, treatment phases, safety considerations, current research, and clinical applications in mental health care. The course explores how psychedelic-assisted therapies are being investigated and implemented internationally for conditions such as treatment-resistant depression, post-traumatic stress disorder (PTSD), anxiety, and psychological distress. Participants will gain an understanding of how therapies involving medicinal psilocybin and MDMA are conducted within controlled clinical settings alongside intensive psychotherapeutic support.

7 Modules1 hour
$169$0
Start Learning
Psychedelic Psychotherapy

Learning Outcomes

What you'll learn

  • Understand the three phases of psychedelic-assisted psychotherapy: preparation, psychedelic experience, and integration.
  • Recognise the importance of non-psychedelic therapeutic elements in ensuring treatment safety and effectiveness.
  • Identify the proposed psychological and emotional benefits associated with psychedelic psychotherapy.
  • Understand how medicinal psilocybin-assisted psychotherapy may support patients with depression.
  • Discuss how medicinal MDMA-assisted psychotherapy may reduce fear and defensiveness in PTSD treatment.
  • Explore the role of therapeutic alliance, preparation, and integration in patient care.
  • Review current international evidence and clinical trials related to psychedelic-assisted therapies.
  • Understand Australia’s evolving clinical research and regulatory environment regarding psychedelic treatments.
  • Recognise ethical, safety, and patient screening considerations.
  • Support informed and evidence-based discussions regarding psychedelic psychotherapy in clinical practice.

Stay updated with our

Healthcare trainingHealthcare training

Training Overview

  • Introduction to Psychedelic Psychotherapy
  • The Three Phases of Psychedelic-Assisted Therapy
  • The Importance of Non-Psychedelic Therapeutic Elements
  • Psilocybin-Assisted Psychotherapy for Depression
  • MDMA-Assisted Psychotherapy for PTSD
  • International Research, Clinical Trials, and Future Directions
  • Summary
Healthcare trainingHealthcare trainingHealthcare trainingHealthcare trainingHealthcare trainingHealthcare trainingHealthcare training

Top reviews

FA

Faida

User fromcare-learning

5

factual information

Posted on 27/05/2026

You May Also Like

Take Your
Learning Anywhere

Stay on top of your learning with the Care Learning app.

Download on the App StoreGet it on Google Play

Are you a qualified
Trainer or Instructor?

Join Care Learning as a trainer and deliver high-quality courses to learners across healthcare and workplace training.

Refer a Friend &
Earn Rewards.

Invite healthcare professionals to join Care Learning and get rewarded when your referral successfully joins.

1 / 3

Frequently asked questions

Psychedelic psychotherapy combines psychotherapy with supervised use of psychedelic-assisted medicines in clinical settings.

The three phases are preparation, the psychedelic experience, and integration.

It is currently being researched for conditions such as treatment-resistant depression and psychological distress.

MDMA may reduce fear and defensiveness, helping patients process trauma more effectively during therapy.

Integration sessions help patients understand and apply insights gained during treatment into daily life.

No. Structured psychotherapy is considered essential for treatment safety and effectiveness.